Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
The Veterans Health Administration has launched initiatives to screen potential patients, to evaluate optimal treatment for participants with...
Among patients with a MET exon 14 skipping mutation, capmatinib produced a response in 41% of previously treated patients and 68% of treatment-...
A survey finds the COVID-19 pandemic to have a significant impact on oncologists’ decision-making.
In recent years, mortality rates have fallen and survival has improved for patients with non–small cell lung cancer.